Navigation Links
MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Preliminary Evidence of Single-Agent Activity in First-in-Human Clinical Study
Date:10/21/2013

ough affiliations with a network of more than 700 physicians in the United States and United Kingdom. Additionally, SCRI offers management, regulatory and other research support services to drug development sponsors and strategic investigator sites. For more information, please visit sarahcannonresearch.com.

Under U.S. law, a new drug cannot be marketed until it has been investigated in clinical trials and approved by the FDA as being safe and effective for the intended use. Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in the forward-looking statements, which are based on management's current expectations and are subject to a number of risks and uncertainties, including, but not limited to, our failure to successfully commercialize our product candidates; costs and delays in the development and/or FDA approval, or the failure to obtain such approval, of our product candidates; uncertainties or differences in interpretation in clinical trial results; our inability to maintain or enter into, and the risks resulting from our dependence upon, collaboration or contractual arrangements necessary for the development, manufacture, commercialization, marketing, sales and distribution of any products; competitive factors; our inability to protect our patents or proprietary rights and obtain necessary rights to third party patents and intellectual property to operate our business; our inability to operate our business without infringing the patents and proprietary rights of others; general economic conditions; the failure of any products to gain market acceptance; our inability to obtain any additional required
'/>"/>

SOURCE MEI Pharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. AstraZeneca Neuroscience partners with ePharmaSolutions to optimize Clinical Trial Management
2. PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry
3. ePharmaSolutions Wins Major Award for Life Sciences Industry Innovation
4. In Q1 Public Biopharmas Shift Fundraising into Overdrive
5. Cumberland Pharmaceuticals And PT. SOHO Industri Pharmasi enter Into Exclusive Licensing Agreement For Caldolor In Indonesia
6. ePharmaSolutions Launches an Innovative Patient Recruitment Application for Windows 8
7. Edison Pharmaceuticals, Inc. signs licensing agreement with Dainippon Sumitomo Pharma Co., Ltd. for development & commercialization of orphan mitochondrial and adult central nervous system disease drugs
8. MEI Pharmas Mitochondrial Inhibitor Drug Candidate ME-344 Named One of Top 10 Oncology Products for 2012
9. Among Newly Diagnosed Type 2 Diabetes Patients, DPP-IV Inhibitors are the Leading Oral Therapies After Standard Metformin and Sulfonylurea
10. MEI Pharma Acquires PWT143, A Highly Selective PI3-Kinase Delta Inhibitor
11. Neurocrine Announces Phase IIb Results Of VMAT2 Inhibitor NBI-98854 For Treatment Of Tardive Dyskinesia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... CHAPEL HILL, N.C. , Aug. 29, 2014 /PRNewswire/ ... the face of regulatory and marketplace changes. CI leaders ... flounder. In a new Best Practices, ... a host of actionable insights, including: - ... and cheaper than primary research - Internal ...
(Date:8/29/2014)... MENLO PARK, Calif. , Aug. 29, 2014 /PRNewswire/ ... Medina Medical as CEO and member of the Board ... three decades of medical device development and commercialization experience, ... Medical,s field. Mr. Engelson previously served as a Partner ... served as President and CEO of two Foundry start-ups. ...
(Date:8/29/2014)... 2014 Research and Markets  has announced the ... 2014" report to their offering. The ... of the largest segments of pharmaceuticals industry. The numbers of ... available therapies were unable to meet the market requirements. There ... CNS disorder, especially over the past two decades. The market ...
Breaking Medicine Technology:Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2US CNS Disorders Drug Pipeline Insight 2014 2
... Owner Pleads Guilty; Dog Wardens Revoke,Snyder County Kennel ... officials are cracking down on unsatisfactory kennels with ... prosecutor and dog,wardens, Special Deputy Agriculture Secretary for ... dog wardens continue to make progress enforcing current,regulations. ...
... Corp.,(Nasdaq: GENZ ) announced today that the ... trial examining the safety and effectiveness of,Clolar(R) (clofarabine) ... leukemia (AML) who are unlikely to benefit from ... to provide substantial,evidence for expanding the current product ...
Cached Medicine Technology:Dog Law Officers' Crackdown on Unsatisfactory Kennels Protecting Animals, Consumers 2Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML 2Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML 3Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML 4Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML 5Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML 6
(Date:8/30/2014)... Franklin, TN (PRWEB) August 30, 2014 ... techniques, including nine mobilizations and six muscle energy techniques. ... also narrates and demonstrates twenty-seven examination techniques for the ... course supports Dr. Reiman's live course presentation with ... Objectives, Applying a differential diagnosis ...
(Date:8/30/2014)... Celebrating its 25th year, Recovery Month ... the fact that millions of Americans lives have ... addiction and mental health disorders. Every September ... programs and other community groups to recognize the ... The rallying theme for Substance Abuse and ...
(Date:8/30/2014)... Barcelona, Spain Saturday 30 August 2014: The first ... They are presented at ESC Congress 2014 by Task ... Aboyans (France). , The "2014 ESC Guidelines on the ... online in European Heart Journal (1) ... "Previous ESC recommendations were published in 2001 but they ...
(Date:8/29/2014)... Daily Gossip writes in its review that ... market nowadays. This method promises to teach readers how to ... some effective alternative sources for the production of energy. ... wind and solar power. , The Home Made Energy ... an eBook. So, this is an online guide that will ...
(Date:8/29/2014)... MD (PRWEB) August 30, 2014 AGH ... by the Doctors in Delaware at Atlantic ... of free health-related services. In addition to no-cost blood ... Maryland offers first aid care at local sports tournaments. ... and other medical staff provide free disease management and ...
Breaking Medicine News(10 mins):Health News:North American Seminars Online PT Continuing Education Course, Examination and Treatment of the SI Joint, Receives Continuing Education Approval in NJ, CA, IL, PA, & TX 2Health News:September is National Recovery Month: What the Connecticut Community for Addiction Recovery (CCAR) Wants You to Know 2Health News:September is National Recovery Month: What the Connecticut Community for Addiction Recovery (CCAR) Wants You to Know 3Health News:First comprehensive ESC Guidelines on aortic diseases published 2Health News:First comprehensive ESC Guidelines on aortic diseases published 3Health News:Home Made Energy Review Exposes Simple Method to Access Alternative Energy Sources 2Health News:Doctors in Delaware from Atlantic General Hospital Offer No-Cost Services to Area Residents 2Health News:Doctors in Delaware from Atlantic General Hospital Offer No-Cost Services to Area Residents 3
... a roadside and rushed to the University of Rochester Medical Center ... doctors were surprised to discover that a trendy tea derived from ... URMC team reported the case study, believed to be the first ... Journal of Emergency Medicine . They described it as ...
... FL (For immediate release) -- Cotinine, a compound derived from ... in a mouse model of Alzheimer,s disease, a study led ... University of South Florida found. The findings are ... in advance of print publication. "We found a compound ...
... the manufacturer of the Alzheimer,s drug memantine submitted a supplementary ... Efficiency in Health Care (IQWiG) sees proof of a benefit ... of a benefit for activities of daily living, at least ... conclusions of the first IQWiG benefit assessment of 2009. IQWiG ...
... Colonoscopy is regarded as the most thorough way ... life-saving procedure can also be painful. Scientists and ... to reduce patient discomfort while also ensuring the ... School of Engineering led by Associate Professor of ...
... Pain researchers from the Sheikh Zayed Institute for Pediatric ... that resiniferatoxin, a drug that has shown early promise as ... body,s ability to fight off bacterial infections, particularly sepsis. ... of the journal Anesthesiology , sheds new light on ...
... percent of American families living above the federal poverty ... the Affordable Care Act, according to a new Commonwealth ... the Massachusetts Institute of Technology (MIT). The report finds ... under the law will make premiums affordable for most ...
Cached Medicine News:Health News:Medical sleuthing linked muscle, kidney problems to kava tea 2Health News:Medical sleuthing linked muscle, kidney problems to kava tea 3Health News:Tobacco-derived compound prevents memory loss in Alzheimer's disease mice 2Health News:Long struggle for appropriately processed manufacturer data leads to a new assessment of memantine 2Health News:Long struggle for appropriately processed manufacturer data leads to a new assessment of memantine 3Health News:A less painful colonoscopy 2Health News:A less painful colonoscopy 3Health News:Study: Resiniferatoxin may increase sepsis-related mortality 2Health News:New study: Health reform to make health insurance affordable for nearly all families 2
The ACE Alera clinical chemistry system serves a wide variety of chemistry diagnostic needs with the power of a large floor model analyzer in an easily integrated and economizing compact footprint of...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: